136 related articles for article (PubMed ID: 17164792)
1. Adenovirus-based prime-boost immunization for rapid vaccination against anthrax.
McConnell MJ; Hanna PC; Imperiale MJ
Mol Ther; 2007 Jan; 15(1):203-10. PubMed ID: 17164792
[TBL] [Abstract][Full Text] [Related]
2. Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein.
Price BM; Liner AL; Park S; Leppla SH; Mateczun A; Galloway DR
Infect Immun; 2001 Jul; 69(7):4509-15. PubMed ID: 11401993
[TBL] [Abstract][Full Text] [Related]
3. Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity.
Hashimoto M; Boyer JL; Hackett NR; Wilson JM; Crystal RG
Infect Immun; 2005 Oct; 73(10):6885-91. PubMed ID: 16177368
[TBL] [Abstract][Full Text] [Related]
4. Mucosal priming of newborn mice with S. Typhi Ty21a expressing anthrax protective antigen (PA) followed by parenteral PA-boost induces B and T cell-mediated immunity that protects against infection bypassing maternal antibodies.
Ramirez K; Ditamo Y; Galen JE; Baillie LW; Pasetti MF
Vaccine; 2010 Aug; 28(37):6065-75. PubMed ID: 20619377
[TBL] [Abstract][Full Text] [Related]
5. Induction of neutralizing antibody responses to anthrax protective antigen by using influenza virus vectors: implications for disparate immune system priming pathways.
Langley WA; Bradley KC; Li ZN; Smith ME; Schnell MJ; Steinhauer DA
J Virol; 2010 Aug; 84(16):8300-7. PubMed ID: 20504926
[TBL] [Abstract][Full Text] [Related]
6. Intramuscular delivery of adenovirus serotype 5 vector expressing humanized protective antigen induces rapid protection against anthrax that may bypass intranasally originated preexisting adenovirus immunity.
Wu S; Zhang Z; Yu R; Zhang J; Liu Y; Song X; Yi S; Liu J; Chen J; Yin Y; Xu J; Hou L; Chen W
Clin Vaccine Immunol; 2014 Feb; 21(2):156-64. PubMed ID: 24307239
[TBL] [Abstract][Full Text] [Related]
7. A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.
Gorantala J; Grover S; Goel D; Rahi A; Jayadev Magani SK; Chandra S; Bhatnagar R
Vaccine; 2011 Jun; 29(27):4521-33. PubMed ID: 21504775
[TBL] [Abstract][Full Text] [Related]
8. A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores.
Hermanson G; Whitlow V; Parker S; Tonsky K; Rusalov D; Ferrari M; Lalor P; Komai M; Mere R; Bell M; Brenneman K; Mateczun A; Evans T; Kaslow D; Galloway D; Hobart P
Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13601-6. PubMed ID: 15342913
[TBL] [Abstract][Full Text] [Related]
9. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
Chitlaru T; Israeli M; Rotem S; Elia U; Bar-Haim E; Ehrlich S; Cohen O; Shafferman A
Vaccine; 2017 Oct; 35(44):6030-6040. PubMed ID: 28342664
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant.
Park YS; Lee JH; Hung CF; Wu TC; Kim TW
Infect Immun; 2008 May; 76(5):1952-9. PubMed ID: 18285494
[TBL] [Abstract][Full Text] [Related]
11. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
Bielinska AU; Janczak KW; Landers JJ; Makidon P; Sower LE; Peterson JW; Baker JR
Infect Immun; 2007 Aug; 75(8):4020-9. PubMed ID: 17502384
[TBL] [Abstract][Full Text] [Related]
12. N-fragment of edema factor as a candidate antigen for immunization against anthrax.
Zeng M; Xu Q; Hesek ED; Pichichero ME
Vaccine; 2006 Jan; 24(5):662-70. PubMed ID: 16157430
[TBL] [Abstract][Full Text] [Related]
13. Cytokine response and survival of mice immunized with an adenovirus expressing Bacillus anthracis protective antigen domain 4.
McConnell MJ; Hanna PC; Imperiale MJ
Infect Immun; 2006 Feb; 74(2):1009-15. PubMed ID: 16428747
[TBL] [Abstract][Full Text] [Related]
14. Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model.
Suryanarayana N; Verma M; Thavachelvam K; Saxena N; Mankere B; Tuteja U; Hmuaka V
Appl Microbiol Biotechnol; 2016 Oct; 100(19):8439-51. PubMed ID: 27364624
[TBL] [Abstract][Full Text] [Related]
15. Passive immunotherapy for anthrax toxin mediated by an adenovirus expressing an anti-protective antigen single-chain antibody.
Kasuya K; Boyer JL; Tan Y; Alipui DO; Hackett NR; Crystal RG
Mol Ther; 2005 Feb; 11(2):237-44. PubMed ID: 15668135
[TBL] [Abstract][Full Text] [Related]
16. Protein- and DNA-based anthrax toxin vaccines confer protection in guinea pigs against inhalational challenge with Bacillus cereus G9241.
Palmer J; Bell M; Darko C; Barnewall R; Keane-Myers A
Pathog Dis; 2014 Nov; 72(2):138-42. PubMed ID: 25044336
[TBL] [Abstract][Full Text] [Related]
17. Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge.
Osorio M; Wu Y; Singh S; Merkel TJ; Bhattacharyya S; Blake MS; Kopecko DJ
Infect Immun; 2009 Apr; 77(4):1475-82. PubMed ID: 19179420
[TBL] [Abstract][Full Text] [Related]
18. Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy.
Baillie LW; Rodriguez AL; Moore S; Atkins HS; Feng C; Nataro JP; Pasetti MF
Vaccine; 2008 Nov; 26(48):6083-91. PubMed ID: 18805452
[TBL] [Abstract][Full Text] [Related]
19. Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis.
Stokes MG; Titball RW; Neeson BN; Galen JE; Walker NJ; Stagg AJ; Jenner DC; Thwaite JE; Nataro JP; Baillie LW; Atkins HS
Infect Immun; 2007 Apr; 75(4):1827-34. PubMed ID: 17145938
[TBL] [Abstract][Full Text] [Related]
20. Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidates.
Yan M; Roehrl MH; Basar E; Wang JY
Vaccine; 2008 Feb; 26(7):947-55. PubMed ID: 18192092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
